HUM vs IBO
Humana Inc (HUM) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IBO currently screens at market cap $7.6M.
Not investment advice. Open the HUM and IBO stock pages for the full models.
Not investment advice.